Cognition Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
0.00 |
41.93 |
21.60 |
117.40 |
| Przychód Δ r/r |
0.00% |
0.00% |
0.00% |
inf% |
-48.48% |
443.52% |
| Przychód (min) |
0.00 |
0.00 |
0.00 |
41.93 |
21.60 |
117.40 |
| Przychód (max) |
0.00 |
0.00 |
0.00 |
41.93 |
21.60 |
117.40 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-33.30 |
-16.19 |
-10.93 |
-10.33 |
-10.33 |
-6.36 |
| Zysk netto % |
-inf% |
-inf% |
-inf% |
-24.64% |
-47.82% |
-5.41% |
| EPS (średnia) |
-0.82 |
-0.41 |
-0.28 |
-0.26 |
-0.26 |
-0.16 |
| Liczba analityków (Przychody) |
0 |
0 |
0 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
4 |
4 |
3 |
1 |
1 |
1 |
| symbol |
CGTX |
CGTX |
CGTX |
CGTX |
CGTX |
CGTX |